Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Triethanolamine Salicylate
Therapeutic Area : Gastroenterology
Study Phase : Approved
Sponsor : Tetra BioPharma
Deal Size : Undisclosed
Deal Type : Partnership
Details : Tetra is finalizing a commercial supply agreement and initiating activities to secure private reimbursement for the two TERPACAN™ products.
Brand Name : Undisclosed
Molecule Type : Small molecule
Upfront Cash : Undisclosed
January 20, 2020
Lead Product(s) : Triethanolamine Salicylate
Therapeutic Area : Gastroenterology
Highest Development Status : Approved
Sponsor : Tetra BioPharma
Deal Size : Undisclosed
Deal Type : Partnership
LOOKING FOR A SUPPLIER?